We are live on ! Find out more
OCRX

Ocera Therapeutics, Inc.
OCRX

Delisted

OCRX was delisted on the 8th of December, 2017.

Back to rankings

0 hedge funds and large institutions have $0 invested in Ocera Therapeutics, Inc. in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 21 → 0 (-21)

100% less capital invested

Capital invested by funds: $5.17M → $0 (-$5.17M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 21

Holders
–
Holders Change
-21
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
21
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$2.32M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$813K
3
HP
Hikari Power
Japan
-$771K
4
VMI
VHCP Management II
New York
-$544K
5
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
-$114K
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
– -$2.32M -2,038,880 Closed
Vanguard Group
2
Vanguard Group
Pennsylvania
– -$813K -713,169 Closed
HP
3
Hikari Power
Japan
– -$771K -676,596 Closed
VMI
4
VHCP Management II
New York
– -$544K -477,269 Closed
Commonwealth Equity Services
5
Commonwealth Equity Services
Massachusetts
– -$114K -100,000 Closed
BlackRock
6
BlackRock
New York
– -$86K -74,716 Closed
AWS
7
AJ Wealth Strategies
New York
– -$71K -62,315 Closed
Geode Capital Management
8
Geode Capital Management
Massachusetts
– -$65K -57,658 Closed
ARTA
9
A.R.T. Advisors
New York
– -$54K -48,077 Closed
PAM
10
Panagora Asset Management
Massachusetts
– -$47K -41,298 Closed
BCM
11
Bridgeway Capital Management
Texas
– -$47K -41,060 Closed
DMK
12
David M. Knott
– -$45K -39,800 Closed
Bank of New York Mellon
13
Bank of New York Mellon
New York
– -$37K -31,880 Closed
California Public Employees Retirement System
14
California Public Employees Retirement System
California
– -$35K -30,711 Closed
GT
15
Glenmede Trust
Pennsylvania
– -$32K -28,200 Closed
Stifel Financial
16
Stifel Financial
Missouri
– -$23K -20,474 Closed
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
– -$23K -20,130 Closed
Northern Trust
18
Northern Trust
Illinois
– -$18K -15,883 Closed
VF
19
Virtu Financial
New York
– -$16K -14,281 Closed
Morgan Stanley
20
Morgan Stanley
New York
– -$6K -4,456 Closed
AG
21
Advisor Group
Arizona
– -$1K -1,200 Closed

OCRX Hedge Fund Activity: Q4 2017 in Review

0 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Ocera Therapeutics, Inc. (OCRX) for Q4 2017, worth a combined $0 — down 100% from $5.17M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of OCRX and 0 opened new positions — a net loss of 21 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Perceptive Advisors, exiting entirely with an estimated $2.32M sold.

  • 0 institutional investors held Ocera Therapeutics, Inc. (OCRX) as of Q4 2017, down from 21 in Q3 2017.
  • Funds reported $0 of Ocera Therapeutics, Inc. stock for Q4 2017, down 100% quarter-over-quarter.
  • 0 funds opened new Ocera Therapeutics, Inc. positions in Q4 2017 and 21 closed out, a net change of -21 holders.
  • The largest Ocera Therapeutics, Inc. seller in Q4 2017 was Perceptive Advisors, an estimated $2.32M sold.

Based on aggregated 13F filings for Q4 2017.